Deepa Jeyakumar, MD | Authors

The Next Generation of Targeted Molecules for the Treatment of Chronic Lymphocytic Leukemia

November 15, 2016

This article describes the clinical data that led to approval of these B-cell receptor inhibitors for the treatment of CLL, and highlights newer agents in clinical development that target the same kinases as the currently available therapies.